Cresco Labs (OTCMKTS:CRLBF) Trading 2.1% Higher - Time to Buy?

Cresco Labs Inc. (OTCMKTS:CRLBF - Get Free Report)'s stock price traded up 2.1% during trading on Tuesday . The company traded as high as $0.91 and last traded at $0.90. 542,895 shares changed hands during trading, a decline of 4% from the average session volume of 568,094 shares. The stock had previously closed at $0.88.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on CRLBF. Roth Capital raised Cresco Labs to a "strong-buy" rating in a research note on Sunday, November 10th. Cormark downgraded Cresco Labs from a "moderate buy" rating to a "hold" rating in a research report on Monday, November 11th. Finally, Atb Cap Markets lowered shares of Cresco Labs from a "strong-buy" rating to a "hold" rating in a research note on Monday, December 9th. Four analysts have rated the stock with a hold rating, two have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, Cresco Labs has a consensus rating of "Moderate Buy" and an average price target of $2.50.

Cresco Labs Trading Down 0.6 %

The company's fifty day moving average is $0.97 and its two-hundred day moving average is $1.37. The company has a quick ratio of 1.39, a current ratio of 1.97 and a debt-to-equity ratio of 1.80. The stock has a market cap of $453.97 million, a price-to-earnings ratio of -4.65 and a beta of 1.79.

Cresco Labs Company Profile

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.